Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 16, 2013The Journal of Pathology

Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants

View Full Paper
Ask AI
Bookmark
Share

Authors

LALaura ArdighieriAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaFZFelix ZeppernickJustus-Liebig-Universität GießenCHCharlotte Gerd HannibalDanish Cancer Society

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ardighieri et al. (2013) studied this question.

synapsesocial.com/papers/6a1bbc08c97d63156a5edc45https://doi.org/10.1002/path.4293
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants2006 · 47 citations
  2. 2Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma2003 · 865 citations
  3. 3EGFR Tyrosine Kinase Domain Mutations Are Detected in Histologically Normal Respiratory Epithelium in Lung Cancer Patients2005 · 272 citations
  4. 4Molecular Genetic Evidence of an Independent Origin of Serous Low Malignant Potential Implants and Lymph Node Inclusions2007 · 26 citations